Skip to main contentAI and Advanced
/
BAJAJHCARE · NSEBSE SENSEX74,314.59-0.03%BSE |
NIFTY 5023,270.6+0.23%NSE |
NIFTY BANK56,055.75-0.42%NSE |
NIFTY IT29,155.6+0.23%NSE |
NIFTY AUTO27,159.15+0.99%NSE |
NIFTY FMCG45,572.7+0.03%NSE |
NIFTY PHARMA26,579.25+1.66%NSE |
NIFTY 50022,654.65+0.54%NSE |
BA
NSE · Equity shares · Biotechnology & Drugs7.25 · 2.26%
Bajaj Healthcare BAJAJHCARE
NSE:INR 328.35
BSE:INR 329.75
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsStale · last-known data
Research sections9 of 9 availableMissing source values remain unavailable, never zero-filled.
AI analysis and Advanced tools for BAJAJHCARE
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 321.1
Day rangeINR 320.4 — INR 333.4
52-week rangeINR 272.35 — INR 541.95
Volume1.40 L
Market cap1,224.69
P/E41.88
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)611.03
Net Income (INR Cr)15.77
Rev Growth (5 Year %)-1.44
EPS Growth (5 Year %)-25.92
P/E Ratio41.88
Book Value158.04
EPS14.44
Price/BV2.08Computed
Research path: Interpret Bajaj Healthcare's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
BAJAJHCAREBajaj Healthcare1d · INR · NSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 923.22 | 833.05 | 765.13 |
| Cash Equivalents | 37.24 | Not available | Not available |
| Other Liabilities Total | 7.18 | 4.98 | 6.14 |
| Long Term Debt | 47.57 | 64.66 | 38.58 |
| Common Stock Total | 16.83 | 15.79 | 13.8 |
| Other Current Assets Total | 145.93 | 85.27 | 82.52 |
| Total Assets | 923.22 | 833.05 | 765.13 |
| Current Portof LT Debt/Capital Leases | 198.54 | 24.49 | 38.07 |
| Cash | 0.75 | 4.45 | 2.93 |
| Total Equity | 533 | 466.16 | 278.36 |
| Long Term Investments | 13.7 | 5.61 | 2.7 |
| Retained Earnings(Accumulated Deficit) | 516.17 | 321.69 | 264.56 |
| Total Common Shares Outstanding | 3.37 | 3.16 | 2.76 |
| Tangible Book Valueper Share Common Eq | 158.04 | 147.15 | 100.2 |
| Total Liabilities | 390.21 | 366.88 | 486.77 |
| Total Debt | 249.09 | 223.25 | 332.82 |
| Short Term Investments | 5.23 | 33.43 | 35.03 |
| Cashand Short Term Investments | 43.21 | 37.88 | 37.95 |
| Total Receivables Net | 233.85 | 272.51 | 212.22 |
| Accounts Receivable-Trade Net | 233.85 | 251.67 | 180.24 |
| Property/Plant/Equipment Total-Net | 255.17 | 240.49 | 257.56 |
| Total Current Liabilities | 332.48 | 296.98 | 441.48 |
| Total Inventory | 216.01 | 162.72 | 144.99 |
| Accounts Payable | 115.28 | 95.47 | 89.43 |
| Other Currentliabilities Total | 18.67 | 43.18 | 58.38 |
| Total Long Term Debt | 50.55 | 64.92 | 39.15 |
| Intangibles Net | 0.98 | 1.4 | 1.81 |
| Other Long Term Assets Total | 10.65 | 18.9 | 21.86 |
| Note Receivable-Long Term | 3.71 | 5.73 | 1.14 |
| Total Current Assets | 639.01 | 560.91 | 480.05 |
| Capital Lease Obligations | 2.99 | 0.25 | 0.57 |
| Accumulated Depreciation Total | Not available | -196.78 | -169.9 |
| Other Equity Total | Not available | -1.45 | Not available |
| Prepaid Expenses | Not available | 2.53 | 2.38 |
| Additional Paid-In Capital | Not available | 130.13 | Not available |
| Property/Plant/Equipment Total-Gross | Not available | 433.82 | 422.66 |
| Notes Payable/Short Term Debt | Not available | 133.84 | 255.6 |
| Deferred Income Tax | Not available | Not available | 0 |
Fundamentals
Valuation and ratios
Growth
Debt 5Yr CAGR %6.61
Margins
Operating Margin 12m7.2
Operating Margin 5y Avg10.52
Net Profit Margin 12m3.49
Net Profit Margin 5y6.26
Yield
Dividend Yield %0.41
Valuation
Price to Sale Ratio2.00
Risk and consensus
Source-qualified signals
Risk metrics
Overall RiskHigh risk
Board Risk49.05
Analyst consensus
Analyst consensus unavailable.
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Sun Pharmaceutical Industries | INR 1,938.1 | 4.65 L | 38.4 | — |
| Divi's Laboratories | INR 7,370 | 1.96 L | 73.32 | — |
| Torrent Pharmaceuticals | INR 4,976.15 | 1.68 L | 72.73 | — |
| Cipla | INR 1,410.7 | 1.14 L | 27.57 | — |
| Zydus Lifesciences | INR 1,122.75 | 1.12 L | 21.19 | — |
Shareholding
Ownership
- Promoter
- 58.59%
- FII
- 2.19%
- MF
- 1.69%
- Other
- 37.53%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Bajaj Healthcare Ltd Falls to 52-Week Low of Rs 273 as Sell-Off Deepens - Markets MojoMarket news · 3 Jun 2026, 2:25 am
Bajaj Healthcare Ltd Falls to 52-Week Low of Rs 273 as Sell-Off Deepens Markets Mojo
Bajaj Healthcare Ltd Technical Momentum Shifts Amid Prolonged Downtrend - Markets MojoMarket news · 2 Jun 2026, 9:05 am
Bajaj Healthcare Ltd Technical Momentum Shifts Amid Prolonged Downtrend Markets Mojo
Bajaj Healthcare Ltd is Rated Strong Sell - Markets MojoMarket news · 30 May 2026, 11:39 am
Bajaj Healthcare Ltd is Rated Strong Sell Markets Mojo
Bajaj Healthcare Downgraded to Strong Sell Amid Weak Technicals and Fundamentals - Markets MojoMarket news · 19 May 2026, 12:30 pm
Bajaj Healthcare Downgraded to Strong Sell Amid Weak Technicals and Fundamentals Markets Mojo
Bajaj Healthcare Ltd Upgraded to Sell by MarketsMOJO Amid Mixed Signals - Markets MojoMarket news · 13 May 2026, 3:19 pm
Bajaj Healthcare Ltd Upgraded to Sell by MarketsMOJO Amid Mixed Signals Markets Mojo
Bajaj Healthcare Ltd Technical Momentum Shifts Amid Bearish Sentiment - Markets MojoMarket news · 13 May 2026, 8:58 am
Bajaj Healthcare Ltd Technical Momentum Shifts Amid Bearish Sentiment Markets Mojo
Corporate actions
Events
- board MeetingsQuarterly Results
- dividendRs.1.5000 per share(30%)Final Dividend
- board MeetingsAudited Results & Final Dividend
- board MeetingsTo consider Fund Raising
- annual General MeetingPOM
- board MeetingsQuarterly Results
- board MeetingsQuarterly Results
- annual General MeetingAGM
Rusaka Markets Community
Discussion and sentiment for Bajaj Healthcare
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Checking your Rusaka Markets account…
Company profile
Business information
What the company does
Bajaj Healthcare Limited is an India-based pharmaceutical company. The Company is engaged in activities of manufacturing, producing, developing and marketing a range of active pharmaceutical ingredients (APIs), bulk drugs, branded and generic formulations. It is focused on development, manufacturing and supply of amino acids, nutritional supplements and API for pharmaceutical, nutraceuticals and food industries. It operates through three segments: APIs, Finished Dosage Formulations (FDFs), and Intermediates. Its APIs include Ascorbic Acid IP, Sodium Ascorbate, Ferrous Ascorbate, and others. Its Intermediary products include Calcium Phosphoryl Choline Chloride (CPCC) and Chlorhexidine (CH Base). It offers a range of FDFs forms, including tablets, caplets, capsules, and oral powders, all available in bulk quantities. The FDFs products include Cholecalciferol Sachet, Ticagrelor Tablet, Pancreatin Capsules, levofloxacin Tablets IP, Bisacodyl Tablet IP, and others.
Company facts
- Industry
- Biotechnology & Drugs
- Sector
- Biotechnology & Drugs
- NSE Code
- BAJAJHCARE
- BSE Code
- 539872
Questions
Stock FAQ
What is the symbol and ISIN of Bajaj Healthcare?
Bajaj Healthcare has the symbol BAJAJHCARE and ISIN - INE411U01027.
What is the current price of Bajaj Healthcare?
Bajaj Healthcare is currently trading at INR 328.35.
What are the year high and year low of Bajaj Healthcare?
Bajaj Healthcare has a year high of INR 541.95 and a year low of INR 272.35.
What is the market capitalization of Bajaj Healthcare?
Bajaj Healthcare has a market capitalization of INR 1,224.69 crore.
What is the P/E ratio of Bajaj Healthcare?
Bajaj Healthcare has a P/E ratio of 41.88.
What is the dividend yield of Bajaj Healthcare?
Bajaj Healthcare has a dividend yield of 0.41%.
How is the financial performance of Bajaj Healthcare based on revenue, net income, and EPS?
Bajaj Healthcare has revenue of INR 611.03 crore, net income of INR 15.77 crore, and EPS of INR 13.32.
What is the book value of Bajaj Healthcare?
Bajaj Healthcare has a book value of INR 158.04.
What is the debt-to-equity ratio of Bajaj Healthcare?
Bajaj Healthcare has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Bajaj Healthcare?
Bajaj Healthcare has a price-to-book ratio of 2.08 and a price-to-sales ratio of 2.00.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.